Almac Clinical Services, a member of the Almac Group, introduced a new state-of-the-art Cryogenic Service Solution at its Durham, NC campus to support cell and gene therapies.    This latest investment from the company’s overall $4million investment to date in cold chain technology in NC includes the Cryogenic Service Solution to ensure an unbroken chain of custody from product line to patient, for sponsors of advanced therapy trials.    The fully contained GMP suite features sop...